Ginkgo Bioworks and Amyris: a new partnership to generate over $300 million in incremental value

John Melo, Ceo of Amyris
John Melo, Ceo of Amyris

Ginkgo Bioworks and Amyris, Inc. announced a new partnership, which will enable the companies to jointly develop products more efficiently and cost effectively, accelerating time to market.
This breakthrough biotech partnership creates clear leadership with a combined offering that has successfully introduced more bio-based products than any other company known in the field. The combined R&D capabilities of Ginkgo and Amyris put both partners at a significant advantage in the industry by leveraging the joint end-to-end technology platform. This partnership is expected to deliver more new cultured ingredients into the global market in the next three years than the total industry has achieved in the last 10 years.

Continue reading